Dose Dependent Activation of Retinoic Acid-Inducible Gene-I Promotes Both Proliferation and Apoptosis Signals in Human Head and Neck Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hu, Jingzhou ^a   He, Yue ^a   Yan, Ming ^a   Zhu, Chao ^a   Ye, Weimin ^a   Zhu, Hanguang ^a   Chen, Wantao ^a   Zhang, Chenping ^a   Zhang, Zhiyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' TRIPHOSPHATE RNA; ANTINEOPLASTIC AGENT; BETA INTERFERON; CASPASE 9; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON RECEPTOR; MESSENGER RNA; PROTEIN KINASE B; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENZYME ACTIVATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LOW DRUG DOSE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84874639267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058273     Document Type: Article

References (33)

1. Tschopp J, Thome M, Hofmann K, Meinl E, (1998) The fight of viruses against apoptosis. Curr Opin Genet Dev 8: 82-87.
2. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
3. Evan GI, (2006) Can't kick that oncogene habit. Cancer Cell 10: 345-347.
4. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA, (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
5. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
6. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
7. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
8. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
9. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
10. Loo YM, Gale M Jr, (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
11. Besch R, Poeck H, Hohenauer T, Senft D, Hacker G, et al. (2009) Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119: 2399-2411.
12. Chattopadhyay S, Yamashita M, Zhang Y, Sen GC, (2011) The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J Virol 85: 3708-3716.
13. Peters K, Chattopadhyay S, Sen GC, (2008) IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol 82: 3500-3508.
14. Rothenberg SM, Ellisen LW, (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest 122: 1951-1957.
15. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, et al. (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567-578.
16. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, et al. (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357: 1705-1715.
17. Kohn AD, Summers SA, Birnbaum MJ, Roth RA, (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378.
18. Cao W, Feng Z, Cui Z, Zhang C, Sun Z, et al. (2011) Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma. Cancer 118: 2858-2871.
19. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, et al. (2002) Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 8: 1168-1171.
20. Davis BK, Wen H, Ting JP, (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735.
21. Elde NC, Malik HS, (2009) The evolutionary conundrum of pathogen mimicry. Nat Rev Microbiol 7: 787-797.
22. van Domselaar R, Bovenschen N (2011) Cell death-independent functions of granzymes: hit viruses where it hurts. Rev Med Virol.
23. Cooray S, (2004) The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol 85: 1065-1076.
24. Jiang Y, Liu XQ, Rajput A, Geng L, Ongchin M, et al. (2011) Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis. Cancer Res 71: 234-244.
25. Dawson CW, Tramountanis G, Eliopoulos AG, Young LS, (2003) Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278: 3694-3704.
26. Swart R, Ruf IK, Sample J, Longnecker R, (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74: 10838-10845.
27. Mori I, Goshima F, Watanabe D, Ito H, Koide N, et al. (2006) Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo. Microbes Infect 8: 1806-1812.
28. Lichtenstein DL, Toth K, Doronin K, Tollefson AE, Wold WS, (2004) Functions and mechanisms of action of the adenovirus E3 proteins. Int Rev Immunol 23: 75-111.
29. Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, et al. (2011) The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem 286: 33580-33590.
30. Kazi A, Sun J, Doi K, Sung SS, Takahashi Y, et al. (2011) The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner. J Biol Chem 286: 9382-9392.
31. Rampias T, Sasaki C, Weinberger P, Psyrri A, (2009) E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 101: 412-423.
32. Leemans CR, Braakhuis BJ, Brakenhoff RH, (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
33. Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, et al. (2008) 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat Med 14: 1256-1263.